Friday, February 7, 2025
wellness India Expo
Home Tags Market

Tag: Market

India to expand global MedTech share to 10-12% by 2030: Anupriya...

Government backs MedTech as a strategic sector, aims for $30 Billion market by 2030

Asia-Pacific healthcare market set to hit $5 trillion by 2030, Driving...

Key growth areas: innovative hospitals, digital health, biotech, and contract research or manufacturing

Mumbai to host 2nd Edition of MEWA 2025, a three-day exhibition...

2nd Edition of MEWA 2025, a three-day exhibition for Nuts and Dry Fruits

Australia oncology devices market to grow by 3% CAGR through 2033,...

Australia accounted for around 10% of the Asia-Pacific (APAC) oncology devices market in 2024, driven by the strong research initiatives and increased government investment

Makers of ORSL introduce WHO ORS in ready-to-drink format

The WHO ORS market in India is currently estimated to be worth ₹300 crores and is growing significantly, outpacing other hydration categories

South Korea Mycobacterium diagnostic tests market set to grow at 3%...

The report reveals that South Korea Mycobacterium tuberculosis tests market accounts for around 8% of the Asia-Pacific market in 2024

Fibroheal raises Rs 6.3 crore funding in Pre Series A round

The company intends to scale up its go to market, recruit more people, invest in their future robust pipeline of products in medical devices area

Loopworm secures prestigious EU TRACES certification for silkworm pupae-derived products, opens...

This milestone positions Loopworm, which operates a GMP+, ISO 22000, and HACCP-certified facility with a 6,000 metric tonnes per annum capacity, as a key player in the EU market for sustainable protein sources

Singapore could become regional accelerator for AI in MedTech: Report

As per a report by APACMed and Bain & Company, the real AI opportunity in Asia-Pacific’s medtech industry lies in its ability to tailor and advance solutions to meet local market demands

‘Gene silencing’ therapies market set to boom, says leading biotech

SynaptixBio, the only company licensed to commercialise a treatment for a rare, deadly disease, says the technology it uses will become widely adopted for the treatment of many diseases